{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:38:45Z","timestamp":1770143925351,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejps.2025.107154","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:08:15Z","timestamp":1748650095000},"page":"107154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia"],"prefix":"10.1016","volume":"211","author":[{"given":"Meng-Yu","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Ting","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Yun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Han","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-Na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Yang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Ben","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107154_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/FTD.0000000000000940","article-title":"Therapeutic drug monitoring of antibiotics: defining the Therapeutic range","volume":"44","author":"Abdul-Aziz","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2025.107154_bib0002","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global burden of disease study 2019","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2025.107154_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106712","article-title":"The impact of daptomycin therapeutic drug monitoring on clinical outcomes: a systematic review","volume":"61","author":"Cairns","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2025.107154_bib0004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00134-013-3187-2","article-title":"Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial","volume":"40","author":"De Waele","year":"2014","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejps.2025.107154_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01818-17","article-title":"Impact of real-time therapeutic drug monitoring on the prescription of antibiotics in burn patients requiring admission to the Intensive care unit","volume":"62","author":"Fournier","year":"2018","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejps.2025.107154_bib0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1469-0691.2009.02701.x","article-title":"Management of methicillin-resistant Staphylococcus aureus infections","volume":"15","author":"Garau","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejps.2025.107154_bib0007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","article-title":"Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial","volume":"48","author":"Hagel","year":"2022","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejps.2025.107154_bib0008","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/jcpt.13366","article-title":"Optimal trough concentration of teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus infection: a systematic review and meta-analysis","volume":"46","author":"Hanai","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejps.2025.107154_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1536","article-title":"Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring, Chinese pharmacological society","volume":"71","author":"He","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QCO.0000000000000494","article-title":"How to optimize antibiotic pharmacokinetic\/pharmacodynamics for gram-negative infections in critically ill patients","volume":"31","author":"Heffernan","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0011","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciac364","article-title":"Persistent methicilin-resistant Staphylococcus aureus bacteremia: resetting the clock for optimal management","volume":"75","author":"Holland","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0012","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/cid\/ciz123","article-title":"Methicillin-susceptible and Methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, In-hospital mortality, length of stay, and cost in the United States","volume":"69","author":"Inagaki","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0013","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccc.2013.03.008","article-title":"Staphylococcus aureus bacteremia, risk factors, complications, and management","volume":"29","author":"Keynan","year":"2013","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.ejps.2025.107154_bib0014","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejps.2025.107154_bib0015","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.967311","article-title":"Expert consensus statement on therapeutic drug monitoring and individualization of linezolid","volume":"10","author":"Lin","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ejps.2025.107154_bib0017","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0018","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia","volume":"36","author":"Lodise","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0019","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciz257","article-title":"Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes","volume":"70","author":"Minejima","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0020","first-page":"10","article-title":"Impact on antibiotic resistance, therapeutic success, and control of side effects in therapeutic drug monitoring (TDM) of daptomycin: a scoping review","author":"Osorio","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejps.2025.107154_bib0021","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/cid\/ciac506","article-title":"Beta-lactam antibiotic therapeutic drug monitoring in critically ill patients: a systematic review and meta-analysis","volume":"75","author":"Pai Mangalore","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0022","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0023","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/jac\/dks153","article-title":"Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients","volume":"67","author":"Pea","year":"2012","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.ejps.2025.107154_bib0024","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jiac.2020.06.006","article-title":"Teicoplanin and therapeutic drug monitoring: an update for optimal use in different patient populations","volume":"26","author":"Pea","year":"2020","journal-title":"J. Infect. ChemOther"},{"key":"10.1016\/j.ejps.2025.107154_bib0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0026","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/jac\/dkv123","article-title":"Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial","volume":"70","author":"Sime","year":"2015","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.ejps.2025.107154_bib0027","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMa"},{"key":"10.1016\/j.ejps.2025.107154_bib0028","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ajg.2013.140","article-title":"Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1","volume":"108","author":"Stickel","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejps.2025.107154_bib0029","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12879-021-06111-w","article-title":"Teicoplanin versus \u03b2-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia","volume":"21","author":"Tsai","year":"2021","journal-title":"BMC. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107154_bib0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus Bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2025.107154_bib0031","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007691-199902000-00010","article-title":"Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis","volume":"21","author":"van Lent-Evers","year":"1999","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2025.107154_bib0032","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with Healthcare-associated infections: summary of data reported to the National healthcare safety network at the centers for disease control and prevention, 2011-2014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.ejps.2025.107154_bib0033","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jcph.2363","article-title":"The influence of a therapeutic drug monitoring service on vancomycin-associated nephrotoxicity","volume":"64","author":"Yang","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107154_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077169","article-title":"Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS. One"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T02:09:04Z","timestamp":1750039744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725001538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":34,"alternative-id":["S0928098725001538"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107154","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107154"}}